Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making
Podcast 1: Bowel Urgency in UC: Impact on Patient Quality of Life and Treatment Selection

Questions marked with a * are required
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
According to the 2016 observational study conducted by Casellas et al, among the ulcerative colitis (UC) symptoms listed below, which did patients consider to be most important when prioritizing their control with treatment:
Sara, a 23-year-old female with a 10-year history of moderate-to-severe UC, recently relocated for work and is referred to your office by her former gastroenterologist. She is currently taking 40 mg adalimumab every other week. During her first visit you ask how she is feeling, to which she responds, “I'm doing okay.” Her fecal calprotectin is 689 μg/mg, suggesting her symptoms are likely more significant than reported. What is the most appropriate strategy for proceeding with Sara’s new-patient health assessment?
Powered by QuestionPro